Curis, Inc. (NASDAQ:CRIS) went down by -14.67% from its latest closing price when compared to the 1-year high value of $2.90 and move down -84.71%, while CRIS stocks collected -12.78% of loss with the last five trading sessions. Press Release reported on 12/06/19 that Curis Provides First-Ever Demonstration that Targeting IRAK4 in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma Results in Anti-Cancer Activity in Ongoing Phase 1 Study
Curis, Inc. (NASDAQ:CRIS) Worth an Investment?
Curis, Inc. (NASDAQ: CRIS) The 36 Months beta value for CRIS stocks is at 2.43, while of the analysts out of 0 who provided ratings for Curis, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $9.00 which is $7.43 above current price. CRIS currently has a short float of 0.42% and public float of 27.52M with average trading volume of 190.97K shares.
CRIS Market Performance
CRIS stocks went down by -12.78% for the week, with the monthly drop of -12.29% and a quarterly performance of -16.49%, while its annual performance rate touched 110.17%. The simple moving average for the period of the last 20 days is -2.54% for CRIS stocks with the simple moving average of -15.36% for the last 200 days.
CRIS Stocks -18.91% Far from 50 Day Moving Average
After a stumble in the market that brought CRIS to its low price for the period of the last 52 weeks, Curis, Inc. was unable to take a rebound, for now settling with -45.86% of loss for the given period.
The stock volatility was left at 12.76%, however, within the period of a single month, the volatility rate increased by 17.39%, while the shares surge at the distance of +4.67% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -37.45% lower at the present time.
In the course of the last 5 trading sessions, CRIS went down by -12.78%, which changed the moving average for the period of 200 days to the total of +44.04% of gains for the stock in comparison to the 20-day moving average settled at $1.61. In addition, Curis, Inc. saw 127.60% in overturn over the period of a single year with a tendency to cut further gains.
CRIS Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Curis, Inc. (CRIS), starting from Dentzer James E, who sold 3,094 shares at the price of $1.16 back on Jan 24. After this action, Rushing now owns 41,639 shares of Curis, Inc., valued at $3,577 with the latest closing price.
Dentzer James E, the President & CEO of Curis, Inc., sold 2,397 shares at the value of $1.09 during a trade that took place back on Jan 23, which means that Dentzer James E is holding 44,733 shares at the value of $2,613 based on the most recent closing price.
CRIS Stock Fundamentals
The current profitability levels are settled at -281.29 for the present operating margin and +92.90 for gross margin. The net margin for Curis, Inc. stands at -312.38. Total capital return value is set at -60.77, while invested capital returns managed to touch -77.78. Equity return holds the value 182.80%, with -64.30% for asset returns.
The value for Enterprise to Sales is 6.69 with debt to enterprise value settled at 1.04. The receivables turnover for Curis, Inc. is 3.51 with the total asset turnover at the value of 0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.11.